|Bid||0.0000 x 46000|
|Ask||0.0000 x 3000|
|Day's Range||1.1200 - 1.2300|
|52 Week Range||0.7000 - 6.0400|
|Beta (5Y Monthly)||0.53|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 08, 2021 - Nov. 12, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.25|
NEW YORK, NY / ACCESSWIRE / October 18, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.
New York, New York--(Newsfile Corp. - October 18, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Sesen Bio securities between December 21, 2020 and August 17, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case ...
SAN FRANCISCO, CA / ACCESSWIRE / October 18, 2021 / Hagens Berman urges Sesen Bio, Inc. (NASDAQ:SESN) investors with losses in excess of $250,000 to submit your losses now.